HP&M Announces that Joseph Cormier has Joined the Firm as an Associate

Hyman, Phelps & McNamara, P.C. is pleased to announce that Joseph (“Jay”) W. Cormier, J.D., Ph.D. has joined the firm as an Associate.  Prior to joining the firm, Dr. Cormier served as a pharmacologist in the Animal Biotechnology Interdisciplinary Group in FDA’s Center for Veterinary Medicine.  While at FDA, Dr. Cormier evaluated the manufacturing of new animal drugs and helped develop policies regarding the regulation of genetically engineered animals.  He is the recipient of several awards, including the FDA Scientific Achievement Award and the Center for Biologics Evaluation and Research Scientific Achievement Award.  Dr. Cormier has extensive knowledge of issues concerning genetic engineering, drug and medical device manufacturing and product promotion, medical device data systems, and mobile medical apps.  He also has experience advising on matters involving general FDA-regulatory compliance policies, product development and FDA-submission strategies, oversight of clinical trials, tobacco product manufacturing, and organic food labeling.

Dr. Cormier graduated from Dartmouth College in 2000 with a Bachelor of Arts in Genetics, Cell, and Developmental Biology modified with Computer Science.  He earned a Master of Arts in Pharmacology in 2001, a Master of Philosophy in Pharmacology in 2003, and a Doctor of Philosophy in Pharmacology in 2005 – all from Columbia University.  Dr. Cormier graduated from Georgetown University Law Center in 2010 with a Juris Doctor, where he served as a Notes Editor for the American Criminal Law Review.  He is admitted to practice law in the District of Columbia, New York, and Massachusetts.  Since leaving FDA, Dr. Cormier has worked as an attorney in private practice representing major pharmaceutical and medical device clients.